Big News at ASH 2016 is Ibrutinib in Treatment of GVHD

Big News at ASH 2016 is Ibrutinib in Treatment of GVHD

User Photo
ASHReport

4 years
674 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David Miklos, MD, PhD of Stanford University Medical Center discusses the big news surrounding ibrutinib for Graft-versus-Host Disease at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>